Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ZHONGCHAOZCMD -3.63%47 EBIT per Share is $-162.06 as of Dec. 2025. GuruFocus rates ZCMD with a GF Score™ of 47/100 and a GF Value™ of $114.09 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 524 Healthcare Providers & Services companies, ZHONGCHAO ranks better than 83.78% on this metric.
ZHONGCHAO's EBIT per Share for the
six
months ended in Dec. 2025 was $-136.21.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $-162.06.
During the past 3 years, the average EBIT per Share Growth Rate was 44.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for ZHONGCHAO's EBIT per Share or its related term are showing as below:
ZCMD'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 23.1 Med: 44.6 Max: 62.4
Current: 44.6
During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of ZHONGCHAO was 62.40% per year. The lowest was 23.10% per year. And the median was 44.60% per year.
ZCMD's 3-Year EBIT Growth Rate is ranked better than 83.78% of 524
companies
in the Healthcare Providers & Services industry
Industry Median: 11.6
vs ZCMD: 44.60
ZHONGCHAO's EBIT for the
six
months ended in Dec. 2025 was $-5.31 Mil.
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
ZHONGCHAO EBIT per Share Related Terms
ZHONGCHAO EBIT per Share Historical Data
* Premium members only.
The historical data trend for ZHONGCHAO's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-162.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ZHONGCHAO (ZCMD) has a EBIT per Share of $-162.06 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on ZHONGCHAO and its competitors. According to the industry distribution chart, ZHONGCHAO ranks #85 out of 524 companies in the Healthcare Providers & Services industry, placing it in the top 16.2%.
Is ZHONGCHAO's EBIT per Share too high?
ZHONGCHAO's current EBIT per Share is $-162.06. Based on the distribution chart, ZHONGCHAO ranks #85 out of 524 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, ZHONGCHAO has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ZHONGCHAO's EBIT per Share compare to ACON and BRGX?
According to the Healthcare Providers & Services industry distribution chart, ZHONGCHAO ranks #85 out of 524 companies for EBIT per Share. This places ZHONGCHAO in the top 16% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 11.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.60, based on 524 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on ZHONGCHAO and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ZHONGCHAO's current EBIT per Share is $-162.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ZHONGCHAO stock overvalued right now?
Based on GuruFocus' analysis, ZHONGCHAO (ZCMD) is currently considered Possible Value Trap. The stock's GF Value™ is $114.09, compared to a current price of $0.88 — trading 99.2% below its estimated fair value. The current EBIT per Share is $-162.06. ZHONGCHAO's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For ZHONGCHAO (ZCMD), the current EBIT per Share is $-162.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ZHONGCHAO (ZCMD) Overvalued in 2026?
Based on GuruFocus' analysis, ZHONGCHAO stock appears to be undervalued.
The current stock price of $0.88 is trading 99.2% below its estimated GF Value™ of $114.09.
GuruFocus considers ZHONGCHAO to be Possible Value Trap.
Key valuation signals for ZCMD:
EBIT per Share: $-162.06
GF Value™: $114.09 vs. price of $0.88 (99.2% below fair value)
No single metric tells the full story. See the ZCMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ZHONGCHAO Inc is an offshore holding company. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provides healthcare information, education, and training services to healthcare professionals under its MDMOOC brand. It also provides focused patient management services through the Zhongxun IT system and WeChat mini program, and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
47GF Score
Get the complete analysis for ZCMD
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZCMD has been successfully added to your 
